Cargando…
MiR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell proliferation in lung adenocarcinoma
BACKGROUND: PSMG3-AS1 has been characterized as an oncogenic lncRNA in breast cancer, while its role in other cancers is unknown. This study investigated the role of PSMG3-AS1 in lung adenocarcinoma (LUAD). METHODS: This study included 64 LUAD patients (42 males and 22 females) who were enrolled bet...
Autores principales: | Yue, Na, Ye, Ming, Zhang, Ran, Guo, Yunquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260832/ https://www.ncbi.nlm.nih.gov/pubmed/32471413 http://dx.doi.org/10.1186/s12890-020-01189-5 |
Ejemplares similares
-
miR-143-3p Targets lncRNA PSMG3-AS1 to Inhibit the Proliferation of Hepatocellular Carcinoma Cells
por: Zhang, Jianlin, et al.
Publicado: (2020) -
miR-4417 targets lncRNA PSMG3-AS1 to suppress cell invasion and migration in cervical squamous cell carcinoma
por: Man, Shuhong, et al.
Publicado: (2021) -
Novel lncRNA PSMG3-AS1 functions as a miR-143-3p sponge to increase the proliferation and migration of breast cancer cells
por: Cui, Yue, et al.
Publicado: (2020) -
miR-449a-5p suppresses CDK6 expression to inhibit cardiomyocyte proliferation
por: Li, Bing, et al.
Publicado: (2021) -
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
por: Bou Kheir, Tony, et al.
Publicado: (2011)